WP
EVH icon

Woodline Partners’s Evolent Health EVH Stock Holding History

Woodline Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,957
Closed -$1.35M – 568
2023
Q4 		$1.35M Buy
+40,957
New +$1.16M 0.01% 395
2023
Q3 		– Sell
-168,500
Closed -$5.11M – 633
2023
Q2 		$5.11M Buy
+168,500
New +$5.45M 0.06% 285
2023
Q1 		– Sell
-264,328
Closed -$7.42M – 681
2022
Q4 		$7.42M Sell
264,328
-200,433
-43% -$5.75M 0.1% 258
2022
Q3 		$16.7M Buy
464,761
+357,864
+335% +$12.6M 0.23% 127
2022
Q2 		$3.28M Buy
+106,897
New +$3.11M 0.05% 321

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Woodline Partners's EVH Position: Q1 2024 in Review

Woodline Partners sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 40,957 shares — an estimated $1.35M sold.

Woodline Partners first reported a position in EVH in Q2 2022 and held it in 5 quarters. The position peaked at $16.7M in Q3 2022. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

  • Woodline Partners reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
  • Woodline Partners sold 40,957 Evolent Health shares in Q1 2024, an estimated $1.35M.
  • Woodline Partners first reported a position in Evolent Health in Q2 2022 and held it in 5 quarters.
  • Woodline Partners's Evolent Health position peaked at $16.7M in Q3 2022.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.